Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Optimization and SAR investigation of novel 2,3-dihydropyrazino[1,2-a]indole-1,4-dione derivatives as EGFR and BRAFV600E dual inhibitors with potent antiproliferative and antioxidant activities
Hesham A. M. Gomaa, Mohamed E. Shaker, Sami I. Alzarea, et al.
Bioorganic Chemistry (2022) Vol. 120, pp. 105616-105616
Closed Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Designing strategies, structural activity relationship and biological activity of recently developed nitrogen containing heterocyclic compounds as epidermal growth factor receptor tyrosinase inhibitors
Rohit Pal, Ghanshyam Teli, Gurubasavaraja Swamy Purawarga Matada, et al.
Journal of Molecular Structure (2023) Vol. 1291, pp. 136021-136021
Closed Access | Times Cited: 31
Therapeutic strategies of dual-target small molecules to overcome drug resistance in cancer therapy
Jing Ye, Junhao Wu, Bo Liu
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 3, pp. 188866-188866
Closed Access | Times Cited: 25
Design, synthesis, and apoptotic antiproliferative action of new 1,2,3-triazole/1,2,4-oxadiazole hybrids as dual EGFR/VEGFR-2 inhibitors
Mohamed A. Mahmoud, Anber F. Mohammed, Ola I. A. Salem, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2024) Vol. 39, Iss. 1
Open Access | Times Cited: 10
Benzimidazole-Based Derivatives as Apoptotic Antiproliferative Agents: Design, Synthesis, Docking, and Mechanistic Studies
Bahaa G. M. Youssif, Martha M. Morcoss, Stefan Bräse, et al.
Molecules (2024) Vol. 29, Iss. 2, pp. 446-446
Open Access | Times Cited: 8
Novel piperine-carboximidamide hybrids: design, synthesis, and antiproliferative activity via a multi-targeted inhibitory pathway
Lamya H. Al-Wahaibi, Mohamed A. Mahmoud, Yaser A. Mostafa, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 38, Iss. 1, pp. 376-386
Open Access | Times Cited: 27
Design, Synthesis, Antiproliferative Actions, and DFT Studies of New Bis–Pyrazoline Derivatives as Dual EGFR/BRAFV600E Inhibitors
Lamya H. Al-Wahaibi, Hesham A. Abou‐Zied, Eman A. M. Beshr, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 9104-9104
Open Access | Times Cited: 15
Nitrogen‐Containing Heterocyclic Scaffolds as EGFR Inhibitors: Design Approaches, Molecular Docking, and Structure‐Activity Relationships
Rohit Pal, Ghanshyam Teli, Gurubasavaraja Swamy Purawarga Matada, et al.
ChemistrySelect (2023) Vol. 8, Iss. 26
Closed Access | Times Cited: 15
Indole Derivatives: A Versatile Scaffold in Modern Drug Discovery—An Updated Review on Their Multifaceted Therapeutic Applications (2020–2024)
Xingyou Mo, Devendra Pratap Rao, Kirandeep Kaur, et al.
Molecules (2024) Vol. 29, Iss. 19, pp. 4770-4770
Open Access | Times Cited: 6
Therapeutic Insights of Indole Scaffold‐Based Compounds as Protein Kinase Inhibitors
Dina H. Dawood
ChemistrySelect (2025) Vol. 10, Iss. 5
Open Access
New antiproliferative 1,3,4-oxadiazole/benzimidazole derivatives: Design, synthesis, and biological evaluation as dual EGFR and BRAFV600E inhibitors
Fatma Fouad Hagar, Samar H. Abbas, Ahmed M. Sayed, et al.
Bioorganic Chemistry (2025) Vol. 157, pp. 108297-108297
Closed Access
Combination therapy and dual-target inhibitors based on cyclin-dependent kinases (CDKs): Emerging strategies for cancer therapy
Qi Hao, Wenzhe Zhao, Zhijia Li, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117465-117465
Closed Access
Design and synthesis of new thiazolidinone/uracil derivatives as antiproliferative agents targeting EGFR and/or BRAFV600E
Mohammed B. Alshammari, Ashraf A. Aly, Bahaa G. M. Youssif, et al.
Frontiers in Chemistry (2022) Vol. 10
Open Access | Times Cited: 23
Synthesis and Biological Evaluation of Indole-2-Carboxamides with Potent Apoptotic Antiproliferative Activity as EGFR/CDK2 Dual Inhibitors
Lamya H. Al-Wahaibi, Yaser A. Mostafa, Mostafa Abdelrahman, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 8, pp. 1006-1006
Open Access | Times Cited: 22
Design, Synthesis, and Antiproliferative Activity of New 5-Chloro-indole-2-carboxylate and Pyrrolo[3,4-b]indol-3-one Derivatives as Potent Inhibitors of EGFRT790M/BRAFV600E Pathways
Lamya H. Al-Wahaibi, Anber F. Mohammed, Mostafa Abdelrahman, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1269-1269
Open Access | Times Cited: 14
New thiophene, thienopyridine and thiazoline-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents and multitargeting kinase inhibitors
Zahra M. Al-Amshany, Nada Y. Tashkandi, Ismail M. M. Othman, et al.
Bioorganic Chemistry (2022) Vol. 127, pp. 105964-105964
Closed Access | Times Cited: 19
A comprehensive review of recent advances in the biological activities of quinazolines
Hesham A. M. Gomaa
Chemical Biology & Drug Design (2022) Vol. 100, Iss. 5, pp. 639-655
Closed Access | Times Cited: 18
Design, synthesis, apoptotic, and antiproliferative effects of 5-chloro-3- (2-methoxyvinyl)-indole-2-carboxamides and pyrido[3,4-b]indol-1-ones as potent EGFR WT/ EGFR T790M inhibitors
Lamya H. Al-Wahaibi, Anber F. Mohammed, Fatema El-Zahraa S. Abdel Rahman, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 11
Design, synthesis, docking and mechanistic studies of new thiazolyl/thiazolidinylpyrimidine-2,4-dione antiproliferative agents
Ashraf A. Aly, Mohammed B. Alshammari, Akil Ahmad, et al.
Arabian Journal of Chemistry (2023) Vol. 16, Iss. 4, pp. 104612-104612
Open Access | Times Cited: 10
Design, Synthesis, and Anti-Proliferative Action of Purine/Pteridine-Based Derivatives as Dual Inhibitors of EGFR and BRAFV600E
Samar El‐Kalyoubi, Hesham A. M. Gomaa, Elshimaa M. N. Abdelhafez, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 5, pp. 716-716
Open Access | Times Cited: 10
New Potential Agents for Malignant Melanoma Treatment—Most Recent Studies 2020–2022
Paweł Kozyra, Danuta Krasowska, Monika Pitucha
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6084-6084
Open Access | Times Cited: 16
One-Pot Synthesis of 1-Thia-4-azaspiro[4.4/5]alkan-3-ones via Schiff Base: Design, Synthesis, and Apoptotic Antiproliferative Properties of Dual EGFR/BRAFV600E Inhibitors
Lamya H. Al-Wahaibi, Essmat M. El‐Sheref, Mohamed M. Hammouda, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 3, pp. 467-467
Open Access | Times Cited: 9
Discovery of new cyanopyridine/chalcone hybrids as dual inhibitors of EGFR/BRAFV600E with promising antiproliferative properties
Hesham A. Abou‐Zied, Eman A. M. Beshr, Hesham A. M. Gomaa, et al.
Archiv der Pharmazie (2022) Vol. 356, Iss. 4
Closed Access | Times Cited: 15
An updated literature on BRAF inhibitors (2018–2023)
Lalmohan Maji, Ghanshyam Teli, Nulgumnalli Manjunathaiah Raghavendra, et al.
Molecular Diversity (2023) Vol. 28, Iss. 4, pp. 2689-2730
Closed Access | Times Cited: 8
Design, Synthesis, and Biological Evaluation of Novel 3-Cyanopyridone/Pyrazoline Hybrids as Potential Apoptotic Antiproliferative Agents Targeting EGFR/BRAFV600E Inhibitory Pathways
Lamya H. Al-Wahaibi, Hesham A. Abou‐Zied, Mohamed Hisham, et al.
Molecules (2023) Vol. 28, Iss. 18, pp. 6586-6586
Open Access | Times Cited: 8
Epidermal growth factor receptor dual-target inhibitors as a novel therapy for cancer: A review
Chao Wang, Yujing Zhang, Tingting Zhang, et al.
International Journal of Biological Macromolecules (2023) Vol. 253, pp. 127440-127440
Closed Access | Times Cited: 8
Page 1 - Next Page

Scroll to top